Functional variants of the serotonin receptor type 3A and B gene are associated with eating disorders

Pharmacogenetics and Genomics

Volumn 19, Issue 10, 2009, Pages 790-799

  Hammer, Christian ^a   Kapeller, Johannes ^a   Endele, Max ^a   Fischer, Christine ^a   Hebebrand, Johannes ^b   Hinney, Anke ^b   Friedel, Susann ^b   Gratacòs, Mònica ^f   Estivill, Xavier ^f,g   Fichter, Manfred ^c,e   Fernández Aranda, Fernando ^h,i   Ehrlich, Stefan ^d   Rappold, Gudrun ^a   Niesler, Beate ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^g UNIVERSITAT POMPEU FABRA   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ Instituto de Salud Carlos III   (Spain)

Author keywords

Anorexia; Eating disorders; HTR3A; HTR3B; Serotonin; Serotonin receptor type 3

Indexed keywords

SEROTONIN 3A RECEPTOR; SEROTONIN 3B RECEPTOR;

ADULT; ANOREXIA NERVOSA; ARTICLE; BULIMIA; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENE REPLICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; EATING DISORDERS; FEMALE; GENETIC VARIATION; HUMANS; MALE; MODELS, BIOLOGICAL; PILOT PROJECTS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3;

EID: 70349560389     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32833132b3     Document Type: Article

References (58)

1. Kendler KS, MacLean C, Neale M, Kessler R, Heath A, Eaves L. The genetic epidemiology of bulimia nervosa. Am J Psychiatry 1991; 148:1627-1637.
2. Bulik CM, Sullivan PF, Kendler KS. Heritability of binge-eating and broadly defined bulimia nervosa. Biol Psychiatry 1998; 44:1210-1218.
3. Sullivan PF, Bulik CM, Kendler KS. Genetic epidemiology of binging and vomiting. Br J Psychiatry 1998; 173:75-79.
4. Holland AJ, Hall A, Murray R, Russell GF, Crisp AH. Anorexia nervosa: a study of 34 twin pairs and one set of triplets. Br J Psychiatry 1984; 145:414-419.
5. Lilenfeld LR, Kaye WH, Greeno CG, Merikangas KR, Plotnicov K, Pollice C, et al. A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch Gen Psychiatry 1998; 55:603-610.
6. Wade TD, Bulik CM, Neale M, Kendler KS. Anorexia nervosa and major depression: shared genetic and environmental risk factors. Am J Psychiatry 2000; 157:469-471.
7. Strober M, Freeman R, Lampert C, Diamond J, Kaye W. Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes. Am J Psychiatry 2000; 157:393-401.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
9. Hinney A, Friedel S, Remschmidt H, Hebebrand J. Genetic risk factors in eating disorders. Am J Pharmacogenomics 2004; 4:209-223.
10. Blundell JE, Lawton CL, Halford JC. Serotonin, eating behavior, and fat intake. Obes Res 1995; 3 (Suppl 4):471S-476S.
11. Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med 2000; 32:222-232.
12. Brewerton TD. Aggression, serotonin, and seasonality. Am J Psychiatry 2001; 158:1335-1336.
13. Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Adv Exp Med Biol 1996; 398:35-41.
14. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S. Molecular cloning of human 5-hydroxytryptamine 3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol 1995; 48:407-416.
15. Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, et al. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 1999; 397:359-363.
16. Niesler B, Frank B, Kapeller J, Rappold GA. Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 2003; 310:101-111.
17. Niesler B, Walstab J, Combrink S, Moller D, Kapeller J, Rietdorf J, et al. Characterization of the novel human serotonin receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E. Mol Pharmacol 2007; 72:8-17.
18. Michel K, Zeller F, Langer R, Nekarda H, Kruger D, Dover TJ, et al. Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. Gastroenterology 2005; 128:1317-1326.
19. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007; 132:397-414.
20. Chameau P, van Hooft JA. Serotonin 5-HT(3) receptors in the central nervous system. Cell Tissue Res 2006; 326:573-581.
21. Hammer VA, Gietzen DW, Beverly JL, Rogers QR. Serotonin3 receptor antagonists block anorectic responses to amino acid imbalance. Am J Physiol 1990; 259:R627-R636.
22. Jiang JC, Gietzen DW. Anorectic response to amino acid imbalance: a selective serotonin3 effect? Pharmacol Biochem Behav 1994; 47:59-63.
23. Washburn BS, Jiang JC, Cummings SL, Dixon K, Gietzen DW. Anorectic responses to dietary amino acid imbalance: effects of vagotomy and tropisetron. Am J Physiol 1994; 266:R1922-R1927.
24. Silverstone PH, Johnson B, Cowen PJ. Does ondansetron attenuate amphetamine-induced behaviour in human volunteers? Psychopharmacology (Berl) 1992; 107:140-141.
25. Ginawi OT, Al-Majed AA, Al-Suwailem AK. Ondansetron, a selective 5-HT3 antagonist, antagonizes methamphetamine-induced anorexia in mice. Pharmacol Res 2005; 51:255-259.
26. Faris PL, Eckert ED, Kim SW, Meller WH, Pardo JV, Goodale RL, et al. Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms. J Affect Disord 2006; 92:79-90.
27. Steffen KJ, Roerig JL, Mitchell JE, Uppala S. Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs 2006; 11:315-336.
28. Ramoz N, Versini A, Gorwood P. Eating disorders: an overview of treatment responses and the potential impact of vulnerability genes and endophenotypes. Expert Opin Pharmacother 2007; 8:2029-2044.
29. Hinney A, Lentes KU, Rosenkranz K, Barth N, Roth H, Ziegler A, et al. Beta 3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa. Int J Obes Relat Metab Disord 1997; 21:224-230.
30. Gabrovsek M, Brecelj-Anderluh M, Bellodi L, Cellini E, Di Bella D, Estivill X, et al. Combined family trio and case-control analysis of the COMT Val158Met polymorphism in European patients with anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet 2004; 124B:68-72.
31. Mercader JM, Ribases M, Gratacos M, Gonzalez JR, Bayes M, de Cid R, et al. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav 2007; 6:706-716.
32. Mercader JM, Saus E, Aguera Z, Bayes M, Boni C, Carreras A, et al. Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders. Hum Mol Genet 2008; 17:1234-1244.
33. Ribases M, Gratacos M, Armengol L, de Cid R, Badia A, Jimenez L, et al. Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry 2003; 8:745-751.
34. Ribases M, Gratacos M, Fernandez-Aranda F, Bellodi L, Boni C, Anderluh M, et al. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet 2004; 13:1205-1212.
35. Ribases M, Gratacos M, Fernandez-Aranda F, Bellodi L, Boni C, Anderluh M, et al. Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet 2005; 13:428-434.
36. Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, Estivill X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007; 23:644-645.
37. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296:2225-2229.
38. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265.
39. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575.
40. Gauderman W, Morrison J. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, http://hydra.usc.edu/ gxe. In, 2006.
41. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs. Holm methods. Am J Public Health 1996; 86:726-728.
42. Sanchez JJ, Phillips C, Borsting C, Balogh K, Bogus M, Fondevila M, et al. A multiplex assay with 52 single nucleotide polymorphisms for human identification. Electrophoresis 2006; 27:1713-1724.
43. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000; 155:945-959.
44. Niesler B, Flohr T, Nothen MM, Fischer C, Rietschel M, Franzek E, et al. Association between the 50 UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 2001; 11:471-475.
45. Niesler B, Weiss B, Fischer C, Nothen MM, Propping P, Bondy B, et al. Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics 2001; 11:21-27.
46. Frank B, Niesler B, Nothen MM, Neidt H, Propping P, Bondy B, et al. Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2004; 131:1-5.
47. Comings DE, MacMurray JP. Molecular heterosis: a review. Mol Genet Metab 2000; 71:19-31.
48. Barrera NP, Herbert P, Henderson RM, Martin IL, Edwardson JM. Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors. Proc Natl Acad Sci U S A 2005; 102:12595-12600.
49. Krzywkowski K, Davies PA, Feinberg-Zadek PL, Brauner-Osborne H, Jensen AA. High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor. Proc Natl Acad Sci U S A 2008; 105:722-727.
50. Walstab J, Hammer C, Bonisch H, Rappold G, Niesler B. Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors. Pharmacogenet Genomics 2008; 18:793-802.
51. Sugai T, Suzuki Y, Sawamura K, Fukui N, Inoue Y, Someya T. The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine. Pharmacogenomics J 2006; 6:351-356.
52. Yamada K, Hattori E, Iwayama Y, Ohnishi T, Ohba H, Toyota T, et al. Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol Psychiatry 2006; 60:192-201.
53. Tremblay PB, Kaiser R, Sezer O, Rosler N, Schelenz C, Possinger K, et al. Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients. J Clin Oncol 2003; 21:2147-2155.
54. Kapeller J, Houghton LA, Monnikes H, Walstab J, Moller D, Bonisch H, et al. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008; 17:2967-2977.
55. Iidaka T, Ozaki N, Matsumoto A, Nogawa J, Kinoshita Y, Suzuki T, et al. A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J Neurosci 2005; 25:6460-6466.
56. Melke J, Westberg L, Nilsson S, Landen M, Soderstrom H, Baghaei F, et al. A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch Gen Psychiatry 2003; 60:1017-1023.
57. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160:636-645.
58. Bulik CM, Hebebrand J, Keski-Rahkonen A, Klump KL, Reichborn-Kjennerud T, Mazzeo SE, et al. Genetic epidemiology, endophenotypes, and eating disorder classification. Int J Eat Disord 2007; 40 (Suppl):S52-S60.